Psoriatic Arthritis - New Drug Offers Relief
Around 7.5 million Americans, which is about 2.2% of the population, suffer from psoriaris, an autoimmune disease causing red, flaky skin...
Mon, 23 Jan 2012 10:00:00 PST


Which Type of Earring and Which Piercing Point Is Safest with Regard to Tearing Through the Ear by an External Force?
Dermatologic Surgery
2/22/2012


Women Who Use Sunless Tanning Products Spend Less Time In The Sun
According to a study published Online First by Archives of Dermatology, one of the JAMA/Archives journals, a survey of young women indicates that those who use sunless tanning products spent less time tanning in the sun or under UV lamps, especially those who use sunless tanning products a lot...
Thu, 05 Jan 2012 09:00:00 PST


Long-Term Effectiveness and Safety of Small-Gel-Particle Hyaluronic Acid for Hand Rejuvenation
Dermatologic Surgery
2/22/2012


ASP2151 for the Treatment of Genital Herpes: A Randomized, Double-Blind, Placebo- and Valacyclovir-Controlled, Dose-Finding Study
The Journal of Infectious Diseases
2/22/2012


All Itches Are Not Equal
New research from Gil Yosipovitch, M.D., Ph.D., professor of dermatology at Wake Forest Baptist Medical Center and a world-renowned itch expert, shows that how good scratching an itch feels is related to the itch's location...
Tue, 31 Jan 2012 00:00:00 PST


Smoke Inhalation Study Yields Surprising Results
A Loyola University Chicago Stritch School of Medicine study includes some unexpected findings about the immune systems of smoke-inhalation patients. Contrary to expectations, patients who died from their injuries had lower inflammatory responses in their lungs than patients who survived...
Mon, 16 Jan 2012 00:00:00 PST


FDA Approves Drug For Common Skin Cancer
On Monday, the US Food and Drug Administration approved a new type of drug to treat adult patients with advanced basal-cell carcinoma, the most common type of skin cancer. The drug's generic name is vismodegib and was developed by the US part of Roche Holding AG. It will be sold in the US by Roche's South San Francisco-based Genentech under the brand name Erivedge...
Wed, 01 Feb 2012 00:00:00 PST


Ginsenoside Rg1 protects human fibroblasts against psoralen- and UVA-induced premature senescence through a telomeric mechanism
Archives of Dermatological Research
2/22/2012


Trends in allergy to the 10 most frequent contact allergens in patients examined at the Nofer Institute, Lodz, Poland in 1996-2009
Advances in Dermatology and Allergology
2/22/2012


Skin Inflammation Controlled By Gatekeeper Signal
A new study unravels key signals that regulate protective and sometimes pathological inflammation of the skin. The research, published online in the journal Immunity by Cell Press, identifies a "gatekeeper" that, when lost, can cause inflammatory skin disease in the absence of injury or infection...
Sat, 28 Jan 2012 00:00:00 PST


Manuka Honey Could Be The Answer For Treating And Preventing Wound Infections
Manuka honey could help clear chronic wound infections and even prevent them from developing in the first place, according to a new study published in Microbiology. The findings provide further evidence for the clinical use of manuka honey to treat bacterial infections in the face of growing antibiotic resistance...
Thu, 02 Feb 2012 00:00:00 PST


German S3-guidelines on the treatment of psoriasis vulgaris
Archives of Dermatological Research
2/22/2012


Silk Spun By Hybrid Silkworms Could Improve Sutures, Artificial Limbs And More
Research has just been published showing that silk produced by transgenically-engineered silkworms in the laboratory of Malcolm Fraser, Jr., professor of biological sciences at University of Notre Dame, exhibits the highly sought-after strength and elasticity of spider silk. This stronger silk could possibly be used to make sutures, artificial limbs and parachutes...
Tue, 10 Jan 2012 00:00:00 PST


Cutaneous Melanoma Risk Higher Among Cancer Survivors
A study published in the December issue of the Archives of Dermatology, one of the JAMA/Archives journals reveals that, cancer survivors have a higher chance of developing cutaneous melanoma (CM), one of the most aggressive forms of skin cancer. Individuals with previously diagnosed melanoma are at the highest risk...
Thu, 05 Jan 2012 09:00:00 PST


Visible Signs Of Aging Improved By Pycnogenol (French Maritime Pine Bark Extract) In New Study
Human skin is the body's first line of defense and often mirrors the health, nutritional status and age of a person. Over time, skin shows signs of aging due to the gradual breakdown of collagen and elastin. However, skin can be rebuilt and made healthier no matter one's age...
Thu, 26 Jan 2012 01:00:00 PST


Risk Factors for Lentigo Maligna Melanoma Compared With Superficial Spreading Melanoma
Archives of Dermatology
2/22/2012


Hidradenitis Suppurativa
Archives of Dermatology
2/22/2012


Lead Levels In Lipstick Much Higher Than Previously Thought
A recent study conducted by the U.S Food And Drug Administration (FDA) reveals that over 400 popular lipstick brands contain twice as much lead as previously believed - up to 7.19 parts per million (ppm). Mark Mitchell, M.D...
Wed, 15 Feb 2012 02:00:00 PST


Unexplained Skin Condition 'Morgellons' Found To Be Non-Infectious, Not Linked To Environmental Cause
The US Centers for Disease Control and Prevention has completed a comprehensive study of an unexplained skin condition commonly referred to as Morgellons and found no infectious agent and no evidence to suggest an environmental link. The full results are reported in the Jan. 25 issue of the online journal PLoS ONE...
Thu, 26 Jan 2012 02:00:00 PST


Zelboraf (vemurafenib), For Deadly Skin Cancer, Approved In Europe
Zelboraf (vemurafenib), manufactured by Roche, has been approved by the European Commission, for treating patients with BRAF V600 mutation-positive metastatic melanoma, a deadly, and dangerous type of skin cancer. Zelboraf works by seeking out the mutated parts of the BRAF protein, found in about 50% of all melanoma cases, and blocking its action. Hal Barron, M.D...
Tue, 21 Feb 2012 06:00:00 PST


Tanning Salons Lie About Health Risks Says Congressional Panel
A report compiled by the U.S. House Energy and Commerce Committee slates tanning salons for not making the risks clear to their customers. The committee asked for a thorough investigation to find out whether tanning salons across the country make it clear to their clients the health issues associated with the services they offer...
Wed, 01 Feb 2012 14:00:00 PST


Children With Severe Burn Injuries Are At A Much Higher Risk Of Health Complications And Death
A study published Online First by The Lancet has found that children with burn injuries covering 60% or more of their total body surface area (TBSA) are at a much higher risk of experiencing severe complications or death. The authors urge the need for more attention to be given to such patients, with more vigilant and improved forms of therapy...
Tue, 31 Jan 2012 09:00:00 PST


Study Published On Novel Treatment For Skin Lymphoma
Promising findings on a novel combination treatment approach for a chronic type of skin lymphoma are published in JAMA's Archives of Dermatology by clinical researchers from Seidman Cancer Center at University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine...
Wed, 18 Jan 2012 02:00:00 PST


Kids Need To Use More Sunscreen
A study published in the journal Pediatrics shows that most pre-adolescent children do not regularly use sunscreen, and worse, many suffer from sunburn at some point during their childhood...
Mon, 23 Jan 2012 15:00:00 PST


Erivedge - Treatment For Most Common Form Of Skin Cancer
Basal cell carcinoma is a form of skin cancer caused by regular sun exposure, or other ultraviolet radiation, which starts in the top layer of the skin (epidermis), is usually painless and grows slowly. The U.S. Food and Drug Administration just approved a new drug named Erivedge (vismodegib) for the treatment of adult patients with basal cell carcinoma, the most common type of skin cancer...
Wed, 01 Feb 2012 09:00:00 PST


Serum and tissue CTACK/CCL27 chemokine levels in early mycosis fungoides and disease control by ifn-a and puva therapy.
British Journal of Dermatology
2/22/2012


Antiestrogen Supplements Might Reduce Melanoma Risk
According to an investigation published in Cancer Prevention Research, a journal of the American Association for Cancer Research, antiestrogen supplements may lower the risk of women with breast cancer developing melanoma. The Swiss Research Foundation against Cancer, a nonprofit group, funded the investigation...
Sun, 08 Jan 2012 00:00:00 PST


Are All Itches The Same? - Probably Not
Gil Yosipovitch, M.D., Ph.D...
Tue, 31 Jan 2012 09:00:00 PST


Impetigo - Ozenoxacin Phase lll Trial
The pharmaceutical company Ferrer has received approval to start phase III human trials of ozenoxacin, formulated as a topical treatment for infectious skin conditions. In February 2012, participants are expected to enter the multicenter, randomized, placebo controlled, parallel, double-blinded superiority clinical study, which is scheduled to complete in 2013...
Fri, 20 Jan 2012 08:00:00 PST


Live Interactive Teledermatology Consultations Lead To Better Clinical Outcomes
According to a report in the January issue of Archives of Dermatology, the use of live interactive teledermatology consultations can lead to improved clinical outcomes for patients, with most the consultations resulting in changes in diagnosis and disease management...
Tue, 17 Jan 2012 15:00:00 PST


New Findings On Aging Pediatric Bruises Published By Notre Dame Researchers
A multi-university research group which includes several University of Notre Dame faculty and graduate students, has recently published a paper detailing new work on the analysis and dating of human bruises. The research, which is funded by the Gerber Foundation, will have particular application to pediatric medicine, as bruise age is often key evidence in child abuse cases...
Mon, 30 Jan 2012 00:00:00 PST


Pyogenic Granuloma: Treatment with the 1,064-nm Long-Pulsed Neodymium-Doped Yttrium Aluminum Garnet Laser in 20 Patients
Dermatologic Surgery
2/22/2012


Dermatologists Find Telemedicine Effective For Patient Care
UC Davis Health System dermatologists, using videoconferencing technology known as telemedicine, have determined that live interactive consultations can improve clinical outcomes for patients because they usually involve beneficial changes in medical diagnosis and disease management that otherwise might not occur...
Thu, 19 Jan 2012 01:00:00 PST


How Our Sense Of Touch Works
According to a study published December 22 in Cell, neuroscientists at Johns Hopkins University School of Medicine have found out how sense of touch is connected in the nervous system and skin. These findings provide new opportunities for understanding how the brain gathers and processes information from hairy skin. David Ginty, Ph.D...
Thu, 12 Jan 2012 09:00:00 PST